Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Novel chiral phosphoric acid catalysis enables high-purity pharmaceutical intermediates with reduced costs and scalable production for global supply chains.
Novel chiral phosphoric acid catalyzed synthesis offers high yield and selectivity for anticancer intermediates ensuring supply chain stability.
Novel 3-step synthesis of chiral imidazolone NHC precursors from bromoacetyl bromide. Enhances asymmetric catalysis efficiency and reduces manufacturing costs for pharmaceutical intermediates.
Discover the novel bis(Amphos) tetrabromo dipalladium complex offering superior stability and catalytic activity for pharmaceutical intermediate manufacturing.
Patent CN106866389A reveals copper-catalyzed asymmetric synthesis. Offers high enantioselectivity up to 95% ee for pharmaceutical intermediates.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for API manufacturing.
Patent CN103214492A details a streamlined A3B porphyrin synthesis reducing solvent use and enabling efficient metalloporphyrin catalysis for industrial oxidation.
Novel anti-Markovnikov hydroamination method using rare earth catalysts offers high purity pharmaceutical intermediates with reduced environmental impact and simplified supply chains.
Patent CN110183341A reveals stable thioester routes for 1,2-dicarbonyl synthesis. Enhance supply chain reliability and reduce manufacturing costs for pharma intermediates.
Patent CN113307790B reveals a metal-free route to 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN110452150B details a novel chiral phosphoric acid catalyzed synthesis of axial chiral indole-naphthalenes, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Patent CN117820316B reveals a novel chiral phosphoric acid catalyzed route for high-purity indolo compounds with significant cost reduction in API manufacturing and supply chain reliability.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of key heterocyclic building blocks.
Discover the novel organocatalytic synthesis of N-N axis chiral bisindoles via patent CN116082217B. High enantioselectivity and cytotoxic activity for advanced drug development.
Novel metal-free oxidative cyclization method for high-purity triazole intermediates. Reduces steps from five to one, ensuring cost-effective supply chain solutions.
Patent CN104520275B details a novel route for 4-oxoquinolone compounds, offering improved stability and cost-effective manufacturing for HIV integrase inhibitor supply chains.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity indole-naphthalene intermediates, offering mild conditions and superior enantioselectivity for scalable API production.
Patent CN114524701B reveals efficient chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with superior cytotoxicity against QGP-1 tumor cells.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.